Fortitude Family Office, LLC
Family OfficePosition in FTRE — Fortrea Holdings Inc.
CIK 1950506
SCOTTSDALE, AZ
Position in FTRE
as of Jun 30, 2026
· filed Jul 20, 2026
Position Value
$28,657
+$28,446 QoQ
Shares Held
1,647
+5782.1% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#21
of 43 holders
Holding Since
Dec 2023
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in FTRE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Fortitude Family Office, LLC holds $736,227 across 148 Biotechnology names. FTRE ranks #6 (3.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
523 | $157,438 | |
| 2 | INCY |
Incyte Corp
|
641 | $72,663 | |
| 3 | RVMD |
Revolution Medicines, Inc.
|
292 | $54,685 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
72 | $35,764 | |
| 5 | JAZZ |
Jazz Pharmaceuticals plc
|
128 | $30,844 | |
| 6 | FTRE |
Fortrea Holdings Inc.
This page
|
1,647 | $28,657 | |
| 7 | RLAY |
Relay Therapeutics, Inc.
|
1,268 | $23,724 | |
| 8 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
228 | $18,584 |
All Filings in FTRE
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $28,657 | 1,647 | Shares | Sole | 2026-07-20 | |
| 2025-03-31 | $211 | 28 | Shares | Sole | 2025-04-16 | |
| 2024-12-31 | $522 | 28 | Shares | Sole | 2025-01-10 | |
| 2024-09-30 | $560 | 28 | Shares | Sole | 2024-10-25 | |
| 2024-06-30 | $653 | 28 | Shares | Sole | 2024-07-10 | |
| 2024-03-31 | $5,980 | 149 | Shares | Sole | 2024-04-11 | |
| 2023-12-31 | $5,200 | 149 | Shares | Sole | 2024-01-12 | |
| No filing history on record for this holder in this stock. | ||||||